56
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Patients’ empowerment, physicians’ perceptions, and achievement of therapeutic goals in patients with type 1 and type 2 diabetes mellitus in Mexico

&
Pages 1349-1357 | Published online: 26 Jul 2016

References

  • VillalpandoSde la CruzVRojasRPrevalence and distribution of type 2 diabetes mellitus in Mexican adult population: a probabilistic surveySalud Publica Mex201052suppl 1S19S2620585724
  • VillalpandoSShamah-LevyTRojasRAguilar-SalinasCATrends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993–2006Salud Publica Mex201052suppl 1S72S7920585732
  • SALUD [webpage on the Internet]Health Statistics: Main Causes of General Mortality in MexicoSINAISMexico Available from: http://www.dgis.salud.gob.mx/contenidos/basesdedatos/BD_Cubos.htmlAccessed April 15, 2016
  • Cantú-BritoCChiqueteERuiz-SandovalJLREACH Latin America Collaborative GroupAtherothrombotic disease, traditional risk factors, and 4-year mortality in a Latin American population: the REACH RegistryClin Cardiol201235845145722653654
  • ChiqueteERuiz-SandovalJLMurillo-BonillaLCentral adiposity and mortality after first-ever acute ischemic strokeEur Neurol2013701–211712323860493
  • BasaldúaNChiqueteECommon predictors of excessive adiposity in children from a region with high prevalence of overweightAnn Nutr Metab200852322723218562789
  • ShichiriMKishikawaHOhkuboYWakeNLong-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patientsDiabetes Care200023suppl 2B2B29
  • ZulligLLGelladWFMoaddebJImproving diabetes medication adherence: successful, scalable interventionsPatient Prefer Adherence2015913914925670885
  • ChanJCGagliardinoJJBaikSHMultifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS)Diabetes Care200932222723319033410
  • RingborgACropetCJönssonBGagliardinoJJRamachandranALindgrenPResource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: results from the International Diabetes Management Practices Study (IDMPS)Int J Clin Pract2009637997100719570117
  • Jeragh-AlhaddadFBWaheediMBarberNDBrockTPBarriers to medication taking among Kuwaiti patients with type 2 diabetes: a qualitative studyPatient Prefer Adherence201591491150326604702
  • WexlerREltonTTaylorCAPleisterAFeldmanDPhysician reported perception in the treatment of high blood pressure does not correspond to practiceBMC Fam Pract2009102319341474
  • McBridePSchrottHGPlaneMBUnderbakkeGBrownRLPrimary care practice adherence to national cholesterol education program guidelines for patients with coronary heart diseaseArch Intern Med199815811123812449625403
  • KimSYChoISLeeJHPhysician factors associated with the blood pressure control among hypertensive patientsJ Prev Med Public Health200740648749418063904
  • Vargas-SánchezAChiqueteELópez-CorralesGEEvaluation of blood pressure measurements in first ambulatory neurological consultations: a missed part of the physical examination?Arch Cardiol Mex201383426326623856317
  • Suzuki-SaitoTYokokawaHShimadaKYasumuraSSelf-perception of glycemic control among Japanese type 2 diabetic patients: accuracy of patient perception and characteristics of patients with misperceptionJ Diabetes Investig201342206213
  • D’SouzaMSKarkadaSNHanrahanNPVenkatesaperumalRAmirtharajADo perceptions of empowerment affect glycemic control and self-care among adults with type 2 diabetes?Glob J Health Sci201575809026156908
  • LeeYJShinSJWangRHLinKDLeeYLWangYHPathways of empowerment perceptions, health literacy, self-efficacy, and self-care behaviors to glycemic control in patients with type 2 diabetes mellitusPatient Educ Couns201699228729426341940
  • VarmingARHansenUMAndrésdóttirGHustedGRWillaingIEmpowerment, motivation, and medical adherence (EMMA): the feasibility of a program for patient-centered consultations to support medication adherence and blood glucose control in adults with type 2 diabetesPatient Prefer Adherence201591243125326366060
  • WongCKWongWCWanYFChanAKChanFWLamCLPatient empowerment programme (PEP) and risk of microvascular diseases among patients with type 2 diabetes in primary care: a population-based propensity-matched cohort studyDiabetes Care2015388e116e11726207061
  • WangRHHsuHCLeeYJShinSJLinKDAnLWPatient empowerment interacts with health literacy to associate with subsequent self-management behaviors in patients with type 2 diabetes: a prospective study in TaiwanPatient Educ Couns Epub201644
  • EbrahimiHSadeghiMAmanpourFVahediHEvaluation of empowerment model on indicators of metabolic control in patients with type 2 diabetes, a randomized clinical trial studyPrim Care Diabetes201610212913526795772
  • TrainaSBMathiasSDColwellHHCrosbyRDAbrahamCThe Diabetes Intention, Attitude, and Behavior Questionnaire: evaluation of a brief questionnaire to measure physical activity, dietary control, maintenance of a healthy weight, and psychological antecedentsPatient Prefer Adherence20161021322227013867
  • SchmittAReimerAHermannsNAssessing diabetes self-management with the diabetes self-management questionnaire (DSMQ) can help analyse behavioural problems related to reduced glycaemic controlPLoS One2016113e015077426938980
  • WongCKWongWCWanYFChanAKChanFWLamCLEffect of a structured diabetes education programme in primary care on hospitalizations and emergency department visits among people with Type 2 diabetes mellitus: results from the Patient Empowerment ProgrammeDiabet Med Epub2015103
  • WongCKWongWCWanEYChanAKChanFWLamCLMacrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP)Endocrine Epub2016119
  • SuzukiTTakeiRInoguchiTClinical significance of barriers to blood glucose control in type 2 diabetes patients with insufficient glycemic controlPatient Prefer Adherence2015983784526170633
  • ChengLLeungDYSitJWFactors associated with diet barriers in patients with poorly controlled type 2 diabetesPatient Prefer Adherence201610374426834464
  • Fanghänel SalmónGSánchez-ReyesLChiquete AnayaEde la Luz CastroJEscalante HerreraARegistro internacional para evaluar la práctica clínica entregada a pacientes con diabetes mellitus tipo 2: Un subanálisis de la experiencia en México. [Multicenter international registry to evaluate the clinical practice delivered to patients with type 2 diabetes mellitus: a sub-analysis of the experience in Mexico]Gac Med Mex2011147322623321743590
  • Lavalle-GonzálezFJChiqueteEde la LuzJIDMPS-3W collaborative group (Mexico)Achievement of therapeutic targets in Mexican patients with diabetes mellitusEndocrinol Nutr2012591059159823137765
  • Sosa-RubíSGGalárragaOLópez-RidauraRDiabetes treatment and control: the effect of public health insurance for the poor in MexicoBull World Health Organ200987751251919649365
  • González-VillalpandoCLópez-RidauraRCampuzanoJCGonzález-VillalpandoMEThe status of diabetes care in Mexican population: are we making a difference? Results of the National Health and Nutrition Survey 2006Salud Publica Mex201052suppl 1S36S4320585727
  • FunnellMMAndersonRMArnoldMSEmpowerment: an idea whose time has come in diabetes educationDiabetes Educ199117137411986902
  • FitzgeraldMO’TuathaighCMoranJInvestigation of the relationship between patient empowerment and glycaemic control in patients with type 2 diabetes: a cross-sectional analysisBMJ Open2015512e008422
  • NorrisSLLauJSmithSJSchmidCHEngelgauMMSelf-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic controlDiabetes Care20022571159117112087014
  • WongCKWongWCLamCLEffects of Patient Empowerment Programme (PEP) on clinical outcomes and health service utilization in type 2 diabetes mellitus in primary care: an observational matched cohort studyPLoS One201495e9532824788804
  • SkylerJSBergenstalRBonowROAmerican Diabetes AssociationAmerican College of Cardiology FoundationAmerican Heart AssociationIntensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart AssociationDiabetes Care200932118719219092168
  • DuckworthWAbrairaCMoritzTGlucose control and vascular complications in veterans with type 2 diabetesN Engl J Med2009360212913919092145
  • Action to Control Cardiovascular Risk in Diabetes Study GroupGersteinHCMillerMEEffects of intensive glucose lowering in type 2 diabetesN Engl J Med2008358242545255918539917
  • ACCORD Study GroupEffects of medical therapies on retinopathy progression in type 2 diabetesN Engl J Med2010363323324420587587
  • MillerMEBondsDEGersteinHCACCORD InvestigatorsThe effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD studyBMJ2010340b544420061360
  • ADVANCE Collaborative GroupPatelAMacMahonSIntensive blood glucose control and vascular outcomes in patients with type 2 diabetesN Engl J Med2008358242560257218539916
  • GagliardinoJJAschnerPBaikSHIDMPS investigatorsPatients’ education, and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS)Diabetes Metab201238212813422019715
  • TunceliKZhaoCDaviesMJFactors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetesPatient Prefer Adherence2015919119725670888